186 related articles for article (PubMed ID: 7526360)
1. Dose and regimen effects of poly ICLC, an interferon inducer, in a multi-dose bleomycin model of interstitial pulmonary fibrosis.
Wild JS; Hyde DM; Giri SN
Pharmacol Toxicol; 1994 Jul; 75(1):42-8. PubMed ID: 7526360
[TBL] [Abstract][Full Text] [Related]
2. Dose-related effects of Ampligen (poly(I).poly(C12U)), a mismatched double-stranded RNA, in a bleomycin-mouse model of pulmonary fibrosis.
Wild JS; Hyde DM; Hubbell HR; Giri SN
Exp Lung Res; 1996; 22(3):375-91. PubMed ID: 8792127
[TBL] [Abstract][Full Text] [Related]
3. Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence.
Giri SN; Hyde DM
Am J Pathol; 1988 Dec; 133(3):525-36. PubMed ID: 2462354
[TBL] [Abstract][Full Text] [Related]
4. Effects of an interferon inducer bropirimine on bleomycin-induced lung fibrosis in hamsters.
Zia S; Hyde DM; Giri SN
Pharmacol Toxicol; 1992 Jul; 71(1):11-8. PubMed ID: 1381833
[TBL] [Abstract][Full Text] [Related]
5. Enhanced induction of plasma interferon after subcutaneous administration in rabbits of poly ICLC with albumin.
Pessina GP; Muscettola M; Paulesu L; Bocci V
J Biol Regul Homeost Agents; 1989; 3(3):118-21. PubMed ID: 2483023
[TBL] [Abstract][Full Text] [Related]
6. Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model.
Iyer SN; Margolin SB; Hyde DM; Giri SN
Exp Lung Res; 1998; 24(1):119-32. PubMed ID: 9457473
[TBL] [Abstract][Full Text] [Related]
7. Interferon induction in piglets with polyinosinic:polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
Loewen KG; Derbyshire JB
Res Vet Sci; 1988 Jan; 44(1):132-3. PubMed ID: 2453906
[TBL] [Abstract][Full Text] [Related]
8. Effect of poly ICLC treatment on hepatic oxidative stress and antioxidant defense indices in Plasmodium yoelii nigeriensis infected mice.
Siddiqi NJ; Alhomida AS; Maheshwari RK; Pandey VC
In Vivo; 2001; 15(1):77-80. PubMed ID: 11286134
[TBL] [Abstract][Full Text] [Related]
9. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
Wang Q; Hyde DM; Gotwals PJ; Giri SN
Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
[TBL] [Abstract][Full Text] [Related]
10. Killing of Leishmania donovani amastigotes by poly ICLC in hamsters.
Bhakuni V; Singha UK; Dutta GP; Levy HB; Maheshwari RK
J Interferon Cytokine Res; 1996 Apr; 16(4):321-5. PubMed ID: 9162526
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of bleomycin-induced lung fibrosis by treatment with the platelet activating factor receptor antagonist WEB 2086 in hamsters.
Giri SN; Sharma AK; Hyde DM; Wild JS
Exp Lung Res; 1995; 21(2):287-307. PubMed ID: 7539741
[TBL] [Abstract][Full Text] [Related]
12. Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology Group.
Giantonio BJ; Hochster H; Blum R; Wiernik PH; Hudes GR; Kirkwood J; Trump D; Oken MM
Invest New Drugs; 2001; 19(1):89-92. PubMed ID: 11291838
[TBL] [Abstract][Full Text] [Related]
13. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis.
Giri SN; Hyde DM; Braun RK; Gaarde W; Harper JR; Pierschbacher MD
Biochem Pharmacol; 1997 Dec; 54(11):1205-16. PubMed ID: 9416971
[TBL] [Abstract][Full Text] [Related]
14. Immunochemotherapy for Leishmania donovani infection in golden hamsters: combinatorial action of poly ICLC plus L-arginine and sodium stibogluconate (Stibanate).
Bhakuni V; Kulkarni S; Ali V; Singh UK; Levy HB; Maheshwari RK
J Interferon Cytokine Res; 1999 Oct; 19(10):1103-6. PubMed ID: 10547149
[TBL] [Abstract][Full Text] [Related]
15. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
Iyer SN; Wild JS; Schiedt MJ; Hyde DM; Margolin SB; Giri SN
J Lab Clin Med; 1995 Jun; 125(6):779-85. PubMed ID: 7539478
[TBL] [Abstract][Full Text] [Related]
16. Liposome-mediated immunotherapy against respiratory influenza virus infection using double-stranded RNA poly ICLC.
Wong JP; Yang H; Nagata L; Kende M; Levy H; Schnell G; Blasetti K
Vaccine; 1999 Mar; 17(13-14):1788-95. PubMed ID: 10194841
[TBL] [Abstract][Full Text] [Related]
17. Effects of niacin on bleomycin-induced increases in myeloperoxidase, prolyl hydroxylase, and superoxide dismutase activities and collagen accumulation in the lungs of hamsters.
O'Neill CA; Giri SN
J Biochem Toxicol; 1992; 7(4):229-39. PubMed ID: 1284083
[TBL] [Abstract][Full Text] [Related]
18. Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling.
Gesuete R; Packard AE; Vartanian KB; Conrad VK; Stevens SL; Bahjat FR; Yang T; Stenzel-Poore MP
J Neurochem; 2012 Nov; 123 Suppl 2(Suppl 2):75-85. PubMed ID: 23050645
[TBL] [Abstract][Full Text] [Related]
19. Increases in lung prolyl hydroxylase and superoxide dismutase activities during bleomycin-induced lung fibrosis in hamsters.
Giri SN; Misra HP; Chandler DB; Chen ZL
Exp Mol Pathol; 1983 Dec; 39(3):317-26. PubMed ID: 6196228
[TBL] [Abstract][Full Text] [Related]
20. Tumor response to interferon inducer and radiation effect of serum interferon levels.
Lvovsky EA; D'Souza J; Eng D; D'Souza D; Lvovsky B; Hetland R; Craver WL; Sobel SH
J Biol Regul Homeost Agents; 1988; 2(1):1-6. PubMed ID: 2459908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]